TP53 and neoplasm: Unlike other tumor-suppressors, missense mutations within the DNA-binding domain represent 75% of all p53 alterations, including six most frequent ‘hotspot’ codons that encompass ~30% of all missense mutations [1], leading to highly stabilized mutant p53 proteins (mutp53).